For hemophilia, a rare blood disorder, comprehensive transitional care, as with any chronic care, is absolutely essential. This chair will allow young hemophilia patients to receive appropriate treatment and the necessary follow-up during the transition from pediatric to adult care.
Patients maintain contact with the hemophilia treatment center for two to four years through consultations with a physician, nurse, and/or psychologist. This is done through a systematic follow-up protocol that includes consultations, musculoskeletal ultrasounds and scores, and pharmacokinetic studies. In addition, various interdisciplinary (12 times a year) and multidisciplinary (4 times a year) meetings are held at various specific times to discuss the transition from pediatrics to adult hematology.
- Chair: Mr. Philip Maes
- Faculty: Medicine and Health Sciences
- Active: since 2019
- Partner:
